Skip to main content

ROYAL BANK OF CANADA

Bank

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 1000275 TORONTO, A6

Position in ACRV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$53
+$19 QoQ
Shares Held
30
+20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 46 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACRV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ACRV ranks #404 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRV

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $53 30
2026-03-31 $34 25
2025-12-31 $4,122 1,711
2025-09-30 $1,715 948
2025-06-30 $35 31
2025-03-31 $1,722 849
2024-12-31 $9,860 1,638
2024-09-30 $8,939 1,277
2024-06-30 $6,472 1,116
2024-03-31 $1,986 278
2023-12-31 $12,240 2,488
2023-09-30 $14,922 1,561
2023-06-30 $11,754 907
2023-03-31 $8,438 665